Analytical Validation of Biomarkers for Early Cancer Detection and Risk Assessment

Description:
The Early Detection Research Network (EDRN) is a scientific consortium of the Division of Cancer Prevention that is organized to validate promising biomarkers for the early detection of and risk assessment for cancer. Researchers who have preliminary development data that suggest a marker is reliable for identifying early cancer or patients at increased cancer risk are encouraged to apply for marker validation through EDRN's Associate Membership Opportunity.

Web Site:
Early Detection Research Network (EDRN) http://cancer.gov/edrn


Availability:
By application through the EDRN Associate Membership Opportunity.

Contact:
Dr. Sudhir Srivastava; ss1a@nih.gov

This page last updated 2007-08-07 11:08:02